Glenbio Ltd

Glenbio Ltd is a private limited company based in Antrim, Northern Ireland, founded in January 2012. Initially focused on distribution and sourcing for the diagnostics industry in the UK and Ireland, Glenbio has expanded to develop and manufacture its own range of clinical chemistry reagents and diagnostic systems, marketed globally under the Glenbio brand. The company specializes in clinical chemistry reagents, veterinary diagnostic products, and COVID-19 testing kits. Their offerings include COVID-19 IgG and IgM ELISA tests and RT-qPCR kits compatible with major platforms. Glenbio serves a diverse customer base in the healthcare and veterinary sectors, providing in vitro diagnostic reagents for various applications, including immunoassay and point-of-care testing. With an estimated annual turnover of approximately £3.9 million, Glenbio has shown healthy growth since its inception. The largest shareholder is John McIntosh, who holds a 54% stake in the company. Glenbio continues to strengthen its presence in the diagnostics market, particularly in COVID-19 testing solutions.

• Employees 19
• Founded 2012
• Annual Revenue $4000000